Closed Systems Drug Transfer Devices Market is expected to reach US$ 1,661.83 Mn With a CAGR of 20.5% from 2020 to 2027 | Yukon Medical, Caragen Ltd., Simplivia Healthcare Ltd., JMS CO., LTD., and Victus, Inc.

According to The Insight Partners market research study of “Closed System Drug Transfer Devices Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Closing Mechanism, Type, Technology, Component, and End User,” the global closed system drug transfer devices market is expected to reach US$ 1,661.83 million by 2027 from US$ 374.48 million in 2019. The market is estimated to grow at a CAGR of 20.5% from 2020 to 2027. The report highlights trends prevailing in the global closed system drug transfer devices market and the factors driving market along with those that act as hindrances.

Download Sample PDF Closed System Drug Transfer Devices Report Copy at: https://www.theinsightpartners.com/sample/TIPRE00004921/ 

Based on technology, the global closed system drug transfer devices market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. The diaphragm-based devices segment held the largest share of the market in 2019. Certain factors, such as superior protection from hazardous drugs and increase in adoption of the devices due to pressure equalization techniques, are responsible for considerable share of the segment in the global market. However, the compartmentalized devices segment is anticipated to register the highest CAGR during the forecast period.

The closed system drug transfer devices market is expected to grow owing to factors such as growing adoption of chemotherapy and improvement of regulatory guidelines regarding hazardous drugs. However, the lack of regulatory guidelines regarding health workers’ safety in emerging countries is expected to restrict the market growth during the forecast period.

The COVID-19 outbreak has also affected the closed system drug transfer devices market across the globe. At present, majority of the manufacturing companies and research institutes and centers are involved in diagnosing the coronavirus and vaccines to treat the deadly virus. Thus, the shift of medical device and research centers and diagnostics laboratories toward the COVID-19 pandemic has hindered the market growth. It is expected that the impact of the pandemic is likely to be seen for a few years.

BD, B. Braun Medical Inc., ICU MEDICAL INC., EQUASHIELD, Corvida Medical, Yukon Medical, Caragen Ltd., Simplivia Healthcare Ltd., JMS CO., LTD., and Victus, Inc. are some of the leading companies operating in the closed system drug transfer devices market.

Market Insights

Growing Adoption of Chemotherapy

Several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics, are used during patient treatment protocols. Pharmacists, physicians, nurses, and other healthcare workers are at significant risk of exposure to hazardous drugs. The cancer treatment comprises the utilization of antineoplastic medications that can cause several health implications if ingested. The antineoplastic can have a severe impact during pregnancies, and the exposure can lead to chromosomal abnormalities. The surface contamination of chemotherapy treatment can impact not only healthcare professionals but also patients and their families. An increasing number of cancer cases are anticipated to drive the adoption of chemotherapies across the globe. For instance, according to the World Health Organization (WHO), in 2018, ~9.6 million deaths were reported due to cancer worldwide. According to the study conducted by the American Cancer Society in 2019–2020, chemotherapy is the most common cancer treatment among stage III breast cancer women as ~56.0% of stage III breast cancer cases prefer chemotherapy in the US. Further, according to the same study, ~43.0% of the patients chose chemotherapy to treat large B-cells during 2012–2016. Thus, the consequent surge in adopting chemotherapies would eventually drive the demand for closed systems drug transfer devices in the coming years.

The report segments the global closed system drug transfer devices market as follows:

By Closing Mechanism

• Push-to-Turn Systems
• Color-to-Color Alignment Systems
• Luer-Lock Systems
• Click-to-Lock Systems

By Type

• Membrane-to-membrane Systems
• Needleless Systems

By Technology

• Diaphragm-Based Devices
• Compartmentalized Devices
• Air Cleaning/Filtration Devices

By Components

• Vial Access Devices
• Syringe Safety Devices
• Bag/Line Access Devices
• Accessories

By End User

• Hospitals & Clinics
• Oncology Centers
• Others

By Geography

• North America
  • • US
    • Canada
    • Mexico
• Europe
  • • France
    • Germany
    • UK
    • Spain
    • Italy
• Asia Pacific (APAC)
  • • China
    • India
    • Japan
    • Australia
    • South Korea
• Middle East & Africa (MEA)
  • • Saudi Arabia
    • U.A.E
    • South Africa
• South & Central America (SCAM)
  • • Brazil
    • Argentina

Buy Complete Closed System Drug Transfer Devices Report at: https://www.theinsightpartners.com/buy/TIPRE00004921/